Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised phase II trial of carboplatin vs docetaxel in metastatic BRCA1/2 breast cancer
2004-001496-20Phase 2Completed
- Sponsor
- University College London
- Start
- Feb 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in breast cancer comparing Carboplatin arm with Docetaxel arm (2 arms). Primary endpoints: Tumor response and Toxicity. Started Feb 2008; status: completed.
02
Drugs
carboplatindocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-001496-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001496-20.